About
Atticus Pharma develops immunodermatology therapeutics using a patented sustained-release technology designed to enhance delivery to the viable epidermis.
Explore Atticus Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.